(Q40129786)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516929%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Confirmation of a BRAF mutation-associated gene expression signature in melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516929%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516929%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Sandra Pavey

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516929%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Nicholas Hayward

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516929%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516929%20AND%20SRC:MED&resulttype=core&format=json

Pigment Cell & Melanoma Research

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516929%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516929%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

216-221

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516929%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516929%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

30 December 2019

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

Malignant melanoma: genetics and therapeutics in the genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

High frequency of BRAF mutations in nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

BRAF mutation predicts sensitivity to MEK inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

BRAF somatic mutations in malignant melanoma and melanocytic naevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

BRAF as a potential therapeutic target in melanoma and other malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X

Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0749.2007.00375.X